VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Agilent Technologies, Inc. vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Agilent Technologies, Inc.
A · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Agilent Technologies, Inc.'s moat claims, evidence, and risks.
View A analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 65 / 100 for Agilent Technologies, Inc.).
- Segment focus: Agilent Technologies, Inc. has 3 segments (41.9% in Agilent CrossLab); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: Agilent Technologies, Inc. has 5 moat types across 2 domains; Sanofi has 5 across 3.
Primary market context
Agilent Technologies, Inc.
Agilent CrossLab
Laboratory services, compliance/maintenance, consumables and lab informatics across the lab workflow
Global
B2B (installed base labs across pharma, diagnostics, academia and applied markets)
Aftermarket services + consumables + informatics
41.9%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
Agilent Technologies, Inc. strengths
Sanofi strengths
Segment mix
Agilent Technologies, Inc. segments
Full profile >Life Sciences and Diagnostics Markets
Oligopoly
Agilent CrossLab
Competitive
Applied Markets
Oligopoly
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.